Roblon (One-pager): Guidance maintained following Q1 2024/25
Read the latest Roblon One-pager update following the Q1 2024/25 results. The One-pager includes a brief description of Roblon, an update to the high-performance cable component industry outlook, latest financials, valuation perspectives relative to a peer group, and outlines several key investment risks and key investment reasons.
For Q1 2024/25 (covering the period 1/11-2024 to 31/01-2025), Roblon reported revenue of DKK 51.1 million (-5.4% YoY), with a strong performance in Composite materials but continued weakness in fiber optic cables. EBITDA came in at DKK 6.7 million, and EBIT reached DKK 3.0 million, up from a small loss in the same quarter last year. The order intake saw significant growth at DKK 86.7 million, up 36% YoY, indicating momentum going into the rest of the year.
To learn more about Roblon, read the full one-pager below or catch up on the presentation of the FY 2023/24 event, hosted with Co-CEO and CFO Carsten Michno. Link: https://www.inderes.dk/videos/roblon-praesentation-af-arsregnskabet-for-202324
Disclaimer: HC Andersen Capital receives payment from Roblon for a DigitalIR/Corporate Visibility subscription agreement. / Philip Coombes 14:45 21/03/2025, updated 11:26 25/03/2025
Roblon
Roblon develops high performance fiber solutions and technologies with a history dating back to 1957, when the company was founded. Roblon produces the fibers, made of fiberglass, aramid etc. that are used to reinforce and protect vital cables in various industries. The company is divided into two main business areas – Fiber Optic Cables (FOC) and Composite. The FOC segment is usually a sub-supplier to large cable producers, where the end customers are typically global internet and telecom providers. The Composite segment is usually a sub-supplier to the producers of wires and cables, which supply global oil & gas companies as well as companies that are active within wind energy. Roblon is headquartered in Frederikshavn (Denmark) and has production facilities in Gærum (Denmark), Hickory, North Carolina (USA) and the recently acquired Vamafil in the Czech Republic. Roblon is thus active with production and sales in both Europe and the USA.
Read more on company page